1-12 of 12
exenatide
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cardiovascular Outcome Trials in Type 2 Diabetes: What Do They Mean for Clinical Practice?

Robert H. Eckel, Azeez Farooki, Robert R. Henry, Gary G. Koch, Lawrence A. Leiter
Journal: Clinical Diabetes
Clin Diabetes 2019;37(4):316–337
DOI: https://doi.org/10.2337/cd19-0001
Published: 01 October 2019
View article
PDF
Journal Articles

ITCA 650

Taylor Bertsch, Kimberly McKeirnan
Journal: Clinical Diabetes
Clin Diabetes 2018;36(3):265–267
DOI: https://doi.org/10.2337/cd18-0039
Published: 01 July 2018
View article
PDF
Journal Articles

Optimizing the Care of Patients With Type 2 Diabetes Using Incretin-Based Therapy: Focus on GLP-1 Receptor Agonists

Mansur Shomali, MD, CM
Journal: Clinical Diabetes
Clin Diabetes 2014;32(1):32–43
DOI: https://doi.org/10.2337/diaclin.32.1.32
Published: 01 January 2014
View article
PDF
Journal Articles

Using Bydureon

Journal: Clinical Diabetes
Clin Diabetes 2012;30(3):134
DOI: https://doi.org/10.2337/diaclin.30.3.134
Published: 01 July 2012
View article
PDF
Journal Articles

Commentary: Exenatide QW: A New Treatment Option for Type 2 Diabetes Offering Ease of Use, Improved Efficacy, and Reduced Side Effects

Charles F. Shaefer, Jr., MD
Journal: Clinical Diabetes
Clin Diabetes 2012;30(3):92–94
DOI: https://doi.org/10.2337/diaclin.30.3.92
Published: 01 July 2012
View article
PDF
Journal Articles

Once-Weekly Glucose-Lowering Therapy for Type 2 Diabetes

Susan LaRue, RD, CDE, Mary Beth DeYoung, PhD, Amy Blickensderfer, PharmD, Steve Chen, MD
Journal: Clinical Diabetes
Clin Diabetes 2012;30(3):95–100
DOI: https://doi.org/10.2337/diaclin.30.3.95
Published: 01 July 2012
View article
PDF
Journal Articles

The Ideal Diabetes Therapy: What Will It Look Like? How Close Are We?

Lisa S. Rotenstein, BA, Benjamin M. Kozak, BA, Joseph P. Shivers, BA, Mark Yarchoan, BA, John Close, MBA, Kelly L. Close, MBA
Journal: Clinical Diabetes
Clin Diabetes 2012;30(2):44–53
DOI: https://doi.org/10.2337/diaclin.30.2.44
Published: 01 April 2012
View article
PDF
Journal Articles

Choosing GLP-1 Receptor Agonists or DPP-4 Inhibitors: Weighing the Clinical Trial Evidence

Timothy Reid, MD
Journal: Clinical Diabetes
Clin Diabetes 2012;30(1):3–12
DOI: https://doi.org/10.2337/diaclin.30.1.3
Published: 01 January 2012
View article
PDF
Journal Articles

Application of Adult-Learning Principles to Patient Instructions: A Usability Study for an Exenatide Once-Weekly Injection Device

Gayle Lorenzi, RN, CDE, Barbara Schreiner, PhD, Joachim Osther, Marilyn Boardman, PharmD
Journal: Clinical Diabetes
Clin Diabetes 2010;28(4):157–162
DOI: https://doi.org/10.2337/diaclin.28.4.157
Published: 01 January 2010
View article
PDF
Journal Articles

Change as a Constant

Tom Elasy, MD, MPH
Journal: Clinical Diabetes
Clin Diabetes 2008;26(2):49–50
DOI: https://doi.org/10.2337/diaclin.26.2.49
Published: 01 April 2008
View article
PDF
Journal Articles

Challenges of Managing Diabetes in Commercial Truck Drivers

Jeremy B. Soule, MD, Leonard E. Egede, MD, MS
Journal: Clinical Diabetes
Clin Diabetes 2007;25(3):110–111
DOI: https://doi.org/10.2337/diaclin.25.3.110
Published: 01 July 2007
View article
PDF
Journal Articles

Glucagon-Like Peptide 1-Based Therapies for Type 2 Diabetes: A Focus on Exenatide

Kathleen Dungan, MD, John B. Buse, MD, PhD
Journal: Clinical Diabetes
Clin Diabetes 2005;23(2):56–62
DOI: https://doi.org/10.2337/diaclin.23.2.56
Published: 01 April 2005
View article
PDF